Advertisement

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Welcome and Introduction to Vi3C

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Advertisement

Advertisement

Jun

29

Today In Oncology

I Miss My Life

AACR Cancer Disparities Progress Report Mortality Rates Improve But Care Inequities Persist

Fertility Preservation Access Remains Limited and Unequal for Many Girls and Young Women With Cancer

Adverse Events With CD3-Based T-Cell–Engaging Bispecific Antibody Treatment in Cancer

Survey Results Show Patients Prefer Learning of a Diagnosis From Their Doctor Rather Than a Health Portal

Advertisement

© 2026 HSP News Service, L.L.C.